Puerto Rico Puerto, the second largest investment destination in the region, is struggling to retain its position as a “viable value proposition” for pharmaceutical companies that have significantly scaled back their investments on the island ...
The Puerto Rico Manufacturers Association rejected the conclusions of a study released this week language and cultural barriers among the employees in companies located in Puerto Rico and their stateside counterparts may be risk factors ...
Less than a year after getting into hot water with the U.S. Food & Drug Administration, Bristol-Myers Squibb in Manatí has reportedly solved its problems and is back in the regulator’s good graces.